European Gram Negative AntiBacterial Engine
The ENABLE project was launched in February 2014 and ended in October 2021 within IMI's 'New Drugs for Bad Bugs' (ND4BB) programme.
The ENABLE consortium worked to advance the development of promising new antibiotic compounds targeting Gram-negative bacteria such as Escherichia coli . The goal of the project was to develop attractive antimicrobial candidates for extensive preclinical studies and First-in-Human clinical trials, bringing new antibiotics to treat Gram-negative infections one step closer to patients.